MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Establishment Labs Holdings Total Assets 2011-2026 | ESTA
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Establishment Labs Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 357 M | 347 M | 269 M | 211 M | 140 M | 156 M | 117 M | 117 M | 57.1 M | 29.6 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 357 M | 29.6 M | 180 M |
Quarterly Total Assets Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 339 M | 330 M | 333 M | 347 M | 283 M | 285 M | 302 M | 269 M | 271 M | 285 M | 209 M | 211 M | 188 M | 200 M | 142 M | 140 M | 148 M | 152 M | 152 M | 156 M | 156 M | 156 M | 156 M | 117 M | 117 M | 117 M | 117 M | 117 M | 117 M | 117 M | 117 M | 57.1 M | 57.1 M | 57.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 347 M | 57.1 M | 186 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.42 | -2.43 % | $ 128 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.96 | -0.95 % | $ 1.62 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.59 | -0.08 % | $ 122 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.14 | -2.56 % | $ 259 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 90.44 | 2.08 % | $ 12.2 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.34 | -1.09 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.79 | -5.79 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.29 | -0.21 % | $ 715 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 54.5 | 0.66 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.22 | -0.48 % | $ 2.96 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.7 | -1.54 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 86.5 | 0.25 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.67 | -5.3 % | $ 28 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 167.2 | -2.72 % | $ 12.5 B | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.72 | -0.4 % | $ 464 M |  Curacao |
 |
AxoGen
AXGN
|
222 M | $ 30.54 | -6.43 % | $ 1.41 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Insulet Corporation
PODD
|
3.19 B | $ 204.83 | 0.65 % | $ 14.4 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.63 | 3.95 % | $ 7.29 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.0 | -3.27 % | $ 847 M | USA |
 |
Smith & Nephew plc
SNN
|
10.5 B | $ 31.7 | -2.85 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 331.21 | -0.33 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 24.24 | -1.38 % | $ 554 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | 1.68 % | $ 37.3 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.68 | 7.69 % | $ 31.9 M | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 107.12 | 2.21 % | $ 3.64 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 18.93 | -1.28 % | $ 1.29 B | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.66 | -0.41 % | $ 346 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.25 | -2.14 % | $ 90.7 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.14 | 1.55 % | $ 1.67 B | USA |